IMR Press / RCM / Volume 10 / Issue 1 / pii/1560997101352-14494143

Reviews in Cardiovascular Medicine (RCM) is published by IMR Press from Volume 19 Issue 1 (2018). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by IMR Press on as a courtesy and upon agreement with MedReviews, LLC.

Open Access Case Review
Lipoproteins, Inflammatory Biomarkers, and Cardiovascular Imaging in the Assessment of Atherosclerotic Disease Activity
Show Less
1 Department of Cardiology, William Beaumont Hospital, Royal Oak, MI
Rev. Cardiovasc. Med. 2009, 10(1), 51–58;
Published: 30 March 2009
Atherosclerosis is present in about 50% of asymptomatic adults at middle age and in nearly all elderly individuals. The traditional diagnostic and treatment paradigm has addressed risk detection and reduction of binary events, including myocardial infarction (MI), stroke, and cardiovascular death. About 50% of all acute coronary syndromes occur in previously asymptomatic subjects, 90% of whom have modifiable risk factors; yet our current screening approaches fail to prevent the 1.2 million acute cardiovascular events that occur annually in the United States. In a patient with active disease, multiple treatment targets can be approached with a variety of lifestyle changes and medical therapy to render the disease quiescent in theory. A future approach may be interception of atherosclerosis before the identification of theoretical or actual risk of episodic events. This case review highlights use of advanced biomarkers and imaging to assess atherosclerotic disease activity in a 49-year-old asymptomatic woman who presents for evaluation after the death of her father from MI.
Coronary artery disease
Lipoprotein-associated phospholipase A2
Cardiac coronary tomography angiography
Back to top